Sandoz Canada has stopped production at its plant in Quebec after the US Food and Drug Administration raised safety and reliability issues at the facility.
Health Shared Services BC says it is working with regional health authorities to deal with the problem.
The agency will monitor all current supplies of Sandoz products, co-ordinate their distribution, find alternative products and work on the issue with the BC Medical Association, pharmacists and Health Canada.
Most of the products are injectable drugs like morphine used in hospitals, as well as a few topical eye products, and hospital patients will be most affected.